1.      Alanin MC, Aanaes K, Hoiby N, Pressler T, Skov M, Nielsen KG, et al. Sinus surgery can improve quality of life, lung infections, and lung function in patients with primary ciliary dyskinesia. Int Forum Allergy Rhinol. 2017;7(3):240-7.

2.      Alanin MC, Nielsen KG, von Buchwald C, Skov M, Aanaes K, Hoiby N, et al. A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia. Clin Microbiol Infect. 2015;21(12):1093 e1-7.

3.      Arndal E, Johansen HK, Haagensen JAJ, Bartell JA, Marvig RL, Alanin M, et al. Primary ciliary dyskinesia patients have the same P. aeruginosa clone in sinuses and lungs. Eur Respir J. 2020;55(1).

4.      Bahceci S, Karaman S, Nacaroglu HT, Yazici S, Girit S, Unsal-Karkiner S, et al. Changing epidemiology of non-cystic fibrosis bronchiectasis. Turk J Pediatr. 2016;58(1):19-26.

5.      Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, Baktai G, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J. 2009;34(6):1264-76.

6.      Behan L, Dimitrov BD, Kuehni CE, Hogg C, Carroll M, Evans HJ, et al. PICADAR: a diagnostic predictive tool for primary ciliary dyskinesia. Eur Respir J. 2016;47(4):1103-12.

7.      Best S, Shoemark A, Rubbo B, Patel MP, Fassad MR, Dixon M, et al. Risk factors for situs defects and congenital heart disease in primary ciliary dyskinesia. Thorax. 2019;74(2):203-5.

8.      Beydon N, Kouis P, Marthin JK, Latzin P, Colas M, Davis SD, et al. Nasal nitric oxide measurement in children for the diagnosis of primary ciliary dyskinesia: European Respiratory Society technical standard. Eur Respir J. 2023;61(4).

9.      Bhatt R, Hogg C. Primary ciliary dyskinesia: a major player in a bigger game. Breathe (Sheff). 2020;16(2):200047.

10.  Bingol I, Gokdemir Y, Yilmaz-Yegit C, Ergenekon P, Atag E, Bas Ikizoglu N, et al. Comparison of conventional chest physiotherapy and oscillatory positive expiratory pressure therapy in primary ciliary dyskinesia. Pediatr Pulmonol. 2020;55(12):3414-20.

11.  Black HA, de Proce SM, Campos JL, Meynert A, Halachev M, Marsh JA, et al. Whole genome sequencing enhances molecular diagnosis of primary ciliary dyskinesia. Pediatr Pulmonol. 2024;59(12):3322-32.

12.  Bonneau D, Raymond F, Kremer C, Klossek JM, Kaplan J, Patte F. Usher syndrome type I associated with bronchiectasis and immotile nasal cilia in two brothers. J Med Genet. 1993;30(3):253-4.

13.  Bukowy-Bieryllo Z, Witt M, Zietkiewicz E. Perspectives for Primary Ciliary Dyskinesia. Int J Mol Sci. 2022;23(8).

14.  Collison R, Hyatali SA, Kamenova A, Rashed A, Riley D, Kumar K, et al. Primary ciliary dyskinesia: Aetiology, diagnosis and clinical management. Clin Med (Lond). 2025;25(3):100319.

15.  Crowley S, Holgersen MG, Nielsen KG. Variation in treatment strategies for the eradication of Pseudomonas aeruginosa in primary ciliary dyskinesia across European centers. Chron Respir Dis. 2019;16:1479972318787919.

16.  Davis SD, Ferkol TW, Rosenfeld M, Lee HS, Dell SD, Sagel SD, et al. Clinical features of childhood primary ciliary dyskinesia by genotype and ultrastructural phenotype. Am J Respir Crit Care Med. 2015;191(3):316-24.

17.  Despotes KA, Zariwala MA, Davis SD, Ferkol TW. Primary Ciliary Dyskinesia: A Clinical Review. Cells. 2024;13(11).

18.  Eralp EE, Gokdemir Y, Atag E, Ikizoglu NB, Ergenekon P, Yegit CY, et al. Changing clinical characteristics of non-cystic fibrosis bronchiectasis in children. BMC Pulm Med. 2020;20(1):172.

19.  Ferkol T. Understanding primary ciliary dyskinesia. Pediatr Pulmonol. 2025;60 Suppl 1:S86-S7.

20.  Gatt D, Shaw M, Waters V, Kritzinger F, Solomon M, Dell S, et al. Treatment response to pulmonary exacerbation in primary ciliary dyskinesia. Pediatr Pulmonol. 2023;58(10):2857-64.

21.  Gatt D, Shaw M, Wee W, Solomon M, Dell SD, Ratjen F. Efficacy of Antibiotic Eradication Therapy of Early Pseudomonas aeruginosa Infection in Children with Primary Ciliary Dyskinesia. Ann Am Thorac Soc. 2023;20(6):854-60.

22.  Gileles-Hillel A, Mor-Shaked H, Shoseyov D, Reiter J, Tsabari R, Hevroni A, et al. Whole-exome sequencing accuracy in the diagnosis of primary ciliary dyskinesia. ERJ Open Res. 2020;6(4).

23.  Gokdemir Y, Karadag-Saygi E, Erdem E, Bayindir O, Ersu R, Karadag B, et al. Comparison of conventional pulmonary rehabilitation and high-frequency chest wall oscillation in primary ciliary dyskinesia. Pediatr Pulmonol. 2014;49(6):611-6.

24.  Hagiwara H, Ohwada N, Takata K. Cell biology of normal and abnormal ciliogenesis in the ciliated epithelium. Int Rev Cytol. 2004;234:101-41.

25.  Hannah WB, Seifert BA, Truty R, Zariwala MA, Ameel K, Zhao Y, et al. The global prevalence and ethnic heterogeneity of primary ciliary dyskinesia gene variants: a genetic database analysis. Lancet Respir Med. 2022;10(5):459-68.

26.  Horani A, Ferkol TW. Understanding Primary Ciliary Dyskinesia and Other Ciliopathies. J Pediatr. 2021;230:15-22 e1.

27.  Kapur N, Masters IB, Morris PS, Galligan J, Ware R, Chang AB. Defining pulmonary exacerbation in children with non-cystic fibrosis bronchiectasis. Pediatr Pulmonol. 2012;47(1):68-75.

28.  Kempeneers C, Chilvers MA. To beat, or not to beat, that is question! The spectrum of ciliopathies. Pediatr Pulmonol. 2018;53(8):1122-9.

29.  Kennedy MP, Omran H, Leigh MW, Dell S, Morgan L, Molina PL, et al. Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation. 2007;115(22):2814-21.

30.  Kobbernagel HE, Buchvald FF, Haarman EG, Casaulta C, Collins SA, Hogg C, et al. Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial. Lancet Respir Med. 2020;8(5):493-505.

31.  Kouis P, Goutaki M, Halbeisen FS, Gioti I, Middleton N, Amirav I, et al. Prevalence and course of disease after lung resection in primary ciliary dyskinesia: a cohort & nested case-control study. Respir Res. 2019;20(1):212.

32.  Kreicher KL, Schopper HK, Naik AN, Hatch JL, Meyer TA. Hearing loss in children with primary ciliary dyskinesia. Int J Pediatr Otorhinolaryngol. 2018;104:161-5.

33.  Lam YT, Papon JF, Alexandru M, Anagiotos A, Armengot M, Boon M, et al. Sinonasal disease among patients with primary ciliary dyskinesia: an international study. ERJ Open Res. 2023;9(3).

34.  Leigh MW, Ferkol TW, Davis SD, Lee HS, Rosenfeld M, Dell SD, et al. Clinical Features and Associated Likelihood of Primary Ciliary Dyskinesia in Children and Adolescents. Ann Am Thorac Soc. 2016;13(8):1305-13.

35.  Lucas JS, Barbato A, Collins SA, Goutaki M, Behan L, Caudri D, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J. 2017;49(1).

36.  Lucas JS, Davis SD, Omran H, Shoemark A. Primary ciliary dyskinesia in the genomics age. Lancet Respir Med. 2020;8(2):202-16.

37.  Lucas JS, Gahleitner F, Amorim A, Boon M, Brown P, Constant C, et al. Pulmonary exacerbations in patients with primary ciliary dyskinesia: an expert consensus definition for use in clinical trials. ERJ Open Res. 2019;5(1).

38.  Marro M, Leiva-Juarez MM, D'Ovidio F, Chan J, Van Raemdonck D, Ceulemans LJ, et al. Lung Transplantation for Primary Ciliary Dyskinesia and Kartagener Syndrome: A Multicenter Study. Transpl Int. 2023;36:10819.

39.  Moore A, Escudier E, Roger G, Tamalet A, Pelosse B, Marlin S, et al. RPGR is mutated in patients with a complex X linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa. J Med Genet. 2006;43(4):326-33.

40.  Mullowney T, Manson D, Kim R, Stephens D, Shah V, Dell S. Primary ciliary dyskinesia and neonatal respiratory distress. Pediatrics. 2014;134(6):1160-6.

41.  Paff T, Omran H, Nielsen KG, Haarman EG. Current and Future Treatments in Primary Ciliary Dyskinesia. Int J Mol Sci. 2021;22(18).

42.  Pazour GJ, Agrin N, Leszyk J, Witman GB. Proteomic analysis of a eukaryotic cilium. J Cell Biol. 2005;170(1):103-13.

43.  Pioch CO, Connell DW, Shoemark A. Primary Ciliary Dyskinesia and Bronchiectasis: New Data and Future Challenges. Arch Bronconeumol. 2023;59(3):134-6.

44.  Raidt J, Riepenhausen S, Pennekamp P, Olbrich H, Amirav I, Athanazio RA, et al. Analyses of 1236 genotyped primary ciliary dyskinesia individuals identify regional clusters of distinct DNA variants and significant genotype-phenotype correlations. Eur Respir J. 2024;64(2).

45.  Rubbo B, Shoemark A, Jackson CL, Hirst R, Thompson J, Hayes J, et al. Accuracy of High-Speed Video Analysis to Diagnose Primary Ciliary Dyskinesia. Chest. 2019;155(5):1008-17.

46.  Satirer O, Mete Yesil A, Emiralioglu N, Tugcu GD, Yalcin E, Dogru D, et al. A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience. Respir Med. 2018;137:35-9.

47.  Shapiro AJ, Davis SD, Ferkol T, Dell SD, Rosenfeld M, Olivier KN, et al. Laterality defects other than situs inversus totalis in primary ciliary dyskinesia: insights into situs ambiguus and heterotaxy. Chest. 2014;146(5):1176-86.

48.  Shapiro AJ, Davis SD, Polineni D, Manion M, Rosenfeld M, Dell SD, et al. Diagnosis of Primary Ciliary Dyskinesia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2018;197(12):e24-e39.

49.  Shapiro AJ, Dell SD, Gaston B, O'Connor M, Marozkina N, Manion M, et al. Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols. Ann Am Thorac Soc. 2020;17(2):e1-e12.

50.  Shapiro AJ, Zariwala MA, Ferkol T, Davis SD, Sagel SD, Dell SD, et al. Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review. Pediatr Pulmonol. 2016;51(2):115-32.

51.  Shoemark A, Boon M, Brochhausen C, Bukowy-Bieryllo Z, De Santi MM, Goggin P, et al. International consensus guideline for reporting transmission electron microscopy results in the diagnosis of primary ciliary dyskinesia (BEAT PCD TEM Criteria). Eur Respir J. 2020;55(4).

52.  Shoemark A, Goutaki M, Kinghorn B, Ardura-Garcia C, Baz-Redon N, Chilvers M, et al. European Respiratory Society and American Thoracic Society guidelines for the diagnosis of Primary Ciliary Dyskinesia. Eur Respir J. 2025.

53.  Sommer JU, Schafer K, Omran H, Olbrich H, Wallmeier J, Blum A, et al. ENT manifestations in patients with primary ciliary dyskinesia: prevalence and significance of otorhinolaryngologic co-morbidities. Eur Arch Otorhinolaryngol. 2011;268(3):383-8.

54.  Strippoli MP, Frischer T, Barbato A, Snijders D, Maurer E, Lucas JS, et al. Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J. 2012;39(6):1482-91.

55.  Vanaken GJ, Bassinet L, Boon M, Mani R, Honore I, Papon JF, et al. Infertility in an adult cohort with primary ciliary dyskinesia: phenotype-gene association. Eur Respir J. 2017;50(5).

56.  Wallmeier J, Frank D, Shoemark A, Nothe-Menchen T, Cindric S, Olbrich H, et al. De Novo Mutations in FOXJ1 Result in a Motile Ciliopathy with Hydrocephalus and Randomization of Left/Right Body Asymmetry. Am J Hum Genet. 2019;105(5):1030-9.

57.  Wallmeier J, Nielsen KG, Kuehni CE, Lucas JS, Leigh MW, Zariwala MA, et al. Motile ciliopathies. Nat Rev Dis Primers. 2020;6(1):77.

58.  Wee WB, Kinghorn B, Davis SD, Ferkol TW, Shapiro AJ. Primary Ciliary Dyskinesia. Pediatrics. 2024;153(6).

59.  Wheway G, Thomas NS, Carroll M, Coles J, Doherty R, Genomics England Research C, et al. Whole genome sequencing in the diagnosis of primary ciliary dyskinesia. BMC Med Genomics. 2021;14(1):234.

60.  Zawawi F, Shapiro AJ, Dell S, Wolter NE, Marchica CL, Knowles MR, et al. Otolaryngology Manifestations of Primary Ciliary Dyskinesia: A Multicenter Study. Otolaryngol Head Neck Surg. 2022;166(3):540-7.